Lazard Asset Management
CDLX icon

Lazard Asset Management’s Cardlytics CDLX Stock Holding History

Lazard Asset Management’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-102
Closed -$22K – 2331
2022
Q2 		$22K Hold
102
– – ﹤0.01% 2108
2022
Q1 		$56K Buy
+102
New +$61.6K ﹤0.01% 1684
2021
Q2 		– Sell
-305
Closed -$334K – 1969
2021
Q1 		$334K Sell
305
-155
-34% -$205K ﹤0.01% 1035
2020
Q4 		$657K Buy
+460
New +$491K ﹤0.01% 943
2020
Q3 		– Sell
-171
Closed -$119K – 1620
2020
Q2 		$119K Buy
171
+63
+58% +$36.4K ﹤0.01% 981
2020
Q1 		$37K Buy
+108
New +$76.5K ﹤0.01% 1289

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
ACM
Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JCM
JS Capital Management New York $109M AUM 34.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lazard Asset Management's CDLX Position: Q3 2022 in Review

Lazard Asset Management sold out of Cardlytics (CDLX) in Q3 2022, closing a stake of 102 shares — an estimated $22K sold.

Lazard Asset Management first reported a position in CDLX in Q1 2020 and held it in 6 quarters. The position peaked at $657K in Q4 2020. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.

  • Lazard Asset Management reported no remaining Cardlytics position as of Q3 2022 after selling out during the quarter.
  • Lazard Asset Management sold 102 Cardlytics shares in Q3 2022, an estimated $22K.
  • Lazard Asset Management first reported a position in Cardlytics in Q1 2020 and held it in 6 quarters.
  • Lazard Asset Management's Cardlytics position peaked at $657K in Q4 2020.
  • 132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.

Based on Lazard Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.